neondrum's blog

Consumer genetics pioneer dnaNUDGE – Finalist of World Technology Award for Health & Medicine – Becomes Member of WTN

London, UK, 24th January 2017 – dnaNUDGE, the developer of the world’s first DNA-based service to “nudge” consumers towards genetically optimal buying behaviour, today announces that it has become a member of the prestigious World Technology Network (WTN), acceding automatically as a finalist in the World Technology Award for Health and Medicine 2016.

For more information read the full news release here:
http://www.neondrum.com/release-display.php?id=1976

Surgical Robot Challenge 2016 Now Open For Entries From International Teams

London, United Kingdom, 18th December 2015 – The world’s pioneering researchers in robotic surgery are invited to showcase their innovative work by taking part in the Surgical Robot Challenge 2016. The Surgical Robot Challenge is open for entry from today, and the competition finals will be held from 20 – 27 June 2016 at the Hamlyn Symposium on Medical Robotics in London, as part of the first ever UK Robotics Week. Full details of the competition and how to enter can be found at: http://roboticsweek.uk/surgicalrobotchallenge.htm.

This international competition annually showcases cutting-edge advances in surgical robot technologies. Teams from around the world will be bringing their surgical robots to London in June to demonstrate their latest innovations. Each team will be given 3 hours to set up and demonstrate their technologies to an independent judging panel of leading surgeons and pioneers in the field, competing for a prize fund of 10,000 GBP.

Key Research on Technologies for Parkinson’s Disease Management Published in IEEE Journal of Biomedical and Health Informatics

London, United Kingdom, 2nd November 2015 – The latest technology advances for the clinical management of Parkinson’s disease are explored in cutting-edge research published today by the IEEE’s Journal of Biomedical and Health Informatics (J-BHI). Authored by distinguished researchers in the field, the papers of the Special Issue on “Enabling Technologies for Parkinson’s Disease Management” are available to download now from the IEEE Xplore® Digital Library via http://jbhi.embs.org/

Parkinson’s disease is the most common neurological movement disorder, with a prevalence of up to 2% in the elderly. The new research published in this Special issue represents the edge between the current technical abilities of engineering solutions and clinical applications for the management of Parkinson’s disease, spanning wearable technologies and the Internet of Things, body sensor networks and smart home techniques.

Major New Papers on Big Data for Health Published in IEEE Journal of Biomedical and Health Informatics

London, UK, 24th July 2015 – A major collection of papers exploring the very latest research and key developments in Big Data for health informatics has been published by the IEEE’s Journal of Biomedical and Health Informatics (J-BHI). Authored by research teams from the world’s leading institutions, the papers of the Special Issue on “Big Data for Health” are available to download now via the IEEE Xplore® Digital Library at http://jbhi.embs.org/2015/07/08/special-issue-big-data-for-health/

ELC Group in early-stage development of novel influenza vaccine

Cambridge, UK, 16th June 2015 – ELC Group, one of the fastest-growing providers of regulatory affairs services, today announces that it has signed up for the early-stage development of a novel vaccine targeting prevention of influenza. The project signals ELC Group’s entry into the pharmaceutical development market.

The vaccine development will be overseen by a specialist R&D team at ELC Group, including regulatory vaccines experts who have worked on and regulated a number of key worldwide paediatric vaccines. The highly experience team includes a number of current advisers to the World Health Organisation.

ELC Group expands into pharmaceutical product development market

Cambridge, UK, 9th June 2015 – ELC Group, one of the fastest-growing providers of regulatory affairs services, today announces that it is expanding into the pharmaceutical development market with the creation of an extensive product portfolio targeting a range of therapeutic areas.

The products, currently under development by an ELC Group specialist team at R&D laboratories will be marketed across the US, EU, LATAM, MENA and China. ELC Group estimates that the complete portfolio will generate an estimated value of 2 Billion USD in annual sales after initial launch. ELC Group intends to sign key strategic global partners for licensing and distribution.

The new product portfolio will address a range of therapeutic areas, including oncology, cardiovascular treatment, diabetes and pain management and ophthalmic solutions. The product set is being developed using the very latest techniques, including advanced technologies such as liposome systems and soft gel.

Pages

Subscribe to RSS - neondrum's blog